Cambridge, UK, 31st January 2023: Mursla Bio was selected as a UK Life Sciences Innovator 2023 in the Diagnostics and Precision Medicine category following a rigorous application process.
The Life Sciences Innovator Showcase is a selective list of UK firms which embody the best of the UK’s life sciences sector, covering 6 key categories: Biopharma and Vaccines, Product and Service Design, Diagnostics and Precision Medicine, Digital Solutions, Medical Technologies, and Medicines Development and Delivery.
The Showcase is sponsored by the UK’s Department for International Trade (DIT), specialising in helping overseas companies set up and invest in the UK and assisting UK companies to succeed in global trade. It was launched yesterday by the UK Minister for Exports, Andrew Bowie, at Arab Health and will continue throughout the year.
To find out more about the UK Life Sciences Innovators Showcase, visit www.lifesciencesinnovator.co.uk
-ENDS-
Contact: Mursla Bio
Sarah Brereton, Director, Limewash
Tel: 07796 583 223
Email: sarah@limewash.co.uk
About Mursla Bio
Mursla is a breakthrough Extracellular Vesicle (EV) characterisation company based on a novel proprietary technology platform, ExoPheno™, which detects the multi-omics cargo of tissue-specific extracellular vesicles in blood for various biomedical applications. Extracellular Vesicles have been shown to reflect the state of their cellular sources, transporting specific ‘-omics’ information (DNA, RNA, proteins, lipids and metabolites) either locally or to distant sites via the circulatory system, including blood.
Discover more: mursla.com